3D bioprinting for the construction of drug testing models-development strategies and regulatory concerns

A drug to be successfully launched in the market requires a significant amount of capital, resources and time, where the unsuccessful results in the last stages lead to catastrophic failure for discovering drugs. This is the very reason which calls for the invention of innovative models that can clo...

Full description

Saved in:
Bibliographic Details
Main Authors: Divya Mallya, Mrunmayi Ashish Gadre, S. Varadharajan, Kirthanashri S. Vasanthan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2025.1457872/full
Tags: Add Tag
No Tags, Be the first to tag this record!